Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
This journal is © The Royal Society of Chemistry..
Recent explosive growth of 'make-on-demand' chemical libraries brought unprecedented opportunities but also significant challenges to the field of computer-aided drug discovery. To address this expansion of the accessible chemical universe, molecular docking needs to accurately rank billions of chemical structures, calling for the development of automated hit-selecting protocols to minimize human intervention and error. Herein, we report the development of an artificial intelligence-driven virtual screening pipeline that utilizes Deep Docking with Autodock GPU, Glide SP, FRED, ICM and QuickVina2 programs to screen 40 billion molecules against SARS-CoV-2 main protease (Mpro). This campaign returned a significant number of experimentally confirmed inhibitors of Mpro enzyme, and also enabled to benchmark the performance of twenty-eight hit-selecting strategies of various degrees of stringency and automation. These findings provide new starting scaffolds for hit-to-lead optimization campaigns against Mpro and encourage the development of fully automated end-to-end drug discovery protocols integrating machine learning and human expertise.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Chemical science - 12(2021), 48 vom: 15. Dez., Seite 15960-15974 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gentile, Francesco [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 21.09.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1039/d1sc05579h |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33558991X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33558991X | ||
003 | DE-627 | ||
005 | 20231225230208.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1039/d1sc05579h |2 doi | |
028 | 5 | 2 | |a pubmed24n1118.xml |
035 | |a (DE-627)NLM33558991X | ||
035 | |a (NLM)35024120 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gentile, Francesco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.09.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a This journal is © The Royal Society of Chemistry. | ||
520 | |a Recent explosive growth of 'make-on-demand' chemical libraries brought unprecedented opportunities but also significant challenges to the field of computer-aided drug discovery. To address this expansion of the accessible chemical universe, molecular docking needs to accurately rank billions of chemical structures, calling for the development of automated hit-selecting protocols to minimize human intervention and error. Herein, we report the development of an artificial intelligence-driven virtual screening pipeline that utilizes Deep Docking with Autodock GPU, Glide SP, FRED, ICM and QuickVina2 programs to screen 40 billion molecules against SARS-CoV-2 main protease (Mpro). This campaign returned a significant number of experimentally confirmed inhibitors of Mpro enzyme, and also enabled to benchmark the performance of twenty-eight hit-selecting strategies of various degrees of stringency and automation. These findings provide new starting scaffolds for hit-to-lead optimization campaigns against Mpro and encourage the development of fully automated end-to-end drug discovery protocols integrating machine learning and human expertise | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Fernandez, Michael |e verfasserin |4 aut | |
700 | 1 | |a Ban, Fuqiang |e verfasserin |4 aut | |
700 | 1 | |a Ton, Anh-Tien |e verfasserin |4 aut | |
700 | 1 | |a Mslati, Hazem |e verfasserin |4 aut | |
700 | 1 | |a Perez, Carl F |e verfasserin |4 aut | |
700 | 1 | |a Leblanc, Eric |e verfasserin |4 aut | |
700 | 1 | |a Yaacoub, Jean Charle |e verfasserin |4 aut | |
700 | 1 | |a Gleave, James |e verfasserin |4 aut | |
700 | 1 | |a Stern, Abraham |e verfasserin |4 aut | |
700 | 1 | |a Wong, Bill |e verfasserin |4 aut | |
700 | 1 | |a Jean, François |e verfasserin |4 aut | |
700 | 1 | |a Strynadka, Natalie |e verfasserin |4 aut | |
700 | 1 | |a Cherkasov, Artem |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chemical science |d 2010 |g 12(2021), 48 vom: 15. Dez., Seite 15960-15974 |w (DE-627)NLM204906237 |x 2041-6520 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2021 |g number:48 |g day:15 |g month:12 |g pages:15960-15974 |
856 | 4 | 0 | |u http://dx.doi.org/10.1039/d1sc05579h |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2021 |e 48 |b 15 |c 12 |h 15960-15974 |